Clotting activity of polyphosphate-functionalized silica nanoparticles.

scientific article published on 4 February 2015

Clotting activity of polyphosphate-functionalized silica nanoparticles. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ANIE.201409639
P932PMC publication ID4782980
P698PubMed publication ID25651530

P50authorStephanie A. SmithQ46924869
James H MorrisseyQ57024638
Anna May-MasnouQ58895679
P2093author name stringGalen D Stucky
Hooman H Rashidi
Gary B Braun
Tracy T Chuong
Riley Allen
Alessia Pallaoro
Damien Kudela
Chi K Nguyen
Nicholas R Parker
Sara Nownes
P2860cites workCauses of death in U.S. Special Operations Forces in the global war on terrorism: 2001-2004Q24681461
Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibilityQ28384598
Analysis of inorganic polyphosphates by capillary gel electrophoresisQ28749589
Polyphosphate as a general procoagulant agentQ33724794
How we choose factor VIII to treat hemophiliaQ34260815
Polyphosphate modulates blood coagulation and fibrinolysis.Q34304738
Polyphosphate exerts differential effects on blood clotting, depending on polymer size.Q34360392
A profile of combat injuryQ35136408
A review of recombinant factor VII for refractory bleeding in nonhemophilic trauma patients.Q36068186
Polyphosphate enhances fibrin clot structureQ36915892
Patterns of mortality and causes of death in polytrauma patients--has anything changed?Q37525189
Hemostatic resuscitation for massive bleeding: the paradigm of plasma and platelets--a review of the current literatureQ37636304
Colchicine-loaded lipid bilayer-coated 50 nm mesoporous nanoparticles efficiently induce microtubule depolymerization upon cell uptake.Q39697983
Toxicity of aluminum silicates used in hemostatic dressings toward human umbilical veins endothelial cells, HeLa cells, and RAW267.4 mouse macrophages.Q39727353
Bioresponsive mesoporous silica nanoparticles for triggered drug releaseQ42597124
An extensive interaction interface between thrombin and factor V is required for factor V activationQ43581648
The causes of death in conventional land warfare: implications for combat casualty care research.Q44452641
Label-free electronic detection of thrombin in blood serum by using an aptamer-based sensor.Q46019141
Size-controlled synthesis of granular polyphosphate nanoparticles at physiologic salt concentrations for blood clottingQ47433438
An alternative hemostatic dressing: comparison of CELOX, HemCon, and QuikClotQ47965904
In vivo assessment of the Combat Ready Clamp to control junctional hemorrhage in swine.Q53112038
Label-Free Electronic Detection of Thrombin in Blood Serum by Using an Aptamer-Based SensorQ58450731
The Effects of QuikClot Combat Gauze, Fluid Resuscitation, and Movement on Hemorrhage Control in a Porcine ModelQ58905408
Preparation and use of polyphosphate-modified zirconia for purification of nucleic acids and proteinsQ72309259
The effect of colloidal silica on blood coagulationQ79067640
P433issue13
P407language of work or nameEnglishQ1860
P921main subjectnanoparticleQ61231
P304page(s)4018-4022
P577publication date2015-02-04
P1433published inAngewandte Chemie International EditionQ62023953
P1476titleClotting activity of polyphosphate-functionalized silica nanoparticles
P478volume54